Skip to main content

Table 4 Cholesterol and TAG content of the lipoprotein fractions in plasma

From: Fish oil and krill oil supplementations differentially regulate lipid catabolic and synthetic pathways in mice

Cholesterol

High fat

FO

KO

K-W

 

mmol/L

mmol/L

mmol/L

p

VLDL

0.11 (0.06–0.12)

0.04 (0.04–0.06)a*, c*

0.10 (0.07–0.12)

0.009

LDL

0.17 (0.14–0.61)

0.32 (0.27–0.37)

0.34 (0.17–0.51)

0.468

HDL

3.10 (2.42–3.36)

1.92 (1.71–2.21)a*

2.46 (1.85–3.15)

0.018

Triacylglycerol

    

VLDL

0.79 (0.42–0.92)

0.20 (0.11–0.30)a*

0.37 (0.32–0.50)

0.004

LDL

0.27 (0.23–0.39)

0.23 (0.09–0.32)

0.20 (0.08–0.25)

0.063

HDL

0.08 (0.04–0.19)

0.06 (0.03–0.13)

0.08 (0.07–0.22)

0.133

  1. Data is shown as median and range. High fat (n = 5), FO (n = 5) and KO (n = 5). a = HF vs. FO, c = FO vs. KO, *= p <0.05 by Dunn’s test. K-W, p indicates the p-value with the Kruskal-Wallace test. FO; fish oil, KO; Krill oil, VLDL; very low density lipoprotein, LDL; low density lipoprotein, HDL; high density lipoprotein.